Xenopatients show the need for precision medicine approach to chemotherapy in ovarian cancer
Jessica Erriquez(Candiolo Cancer Institute), Giorgio Valabrega(CTO Hospital)
Cited by 16
Related Papers
TOP2A as marker of response to pegylated lyposomal doxorubicin (PLD) in epithelial ovarian cancers
|Journal of Ovarian Research|2019|33